Resources>Blog>AI and Computational Approaches in Antibody Research

AI and Computational Approaches in Antibody Research

Biointron 2024-01-24 Read time: 1 min
AI.jpg
Image credit: DOI: 10.3390/ijerph18010271

Artificial intelligence (AI) and computational methods are a powerful tool for antibody discovery and engineering. Despite historical prevalence in small molecule-related applications, AI is progressively being utilized in the discovery and advancement of therapeutic antibodies, backed by the surge in computational power and innovative algorithms, with an increasing amount of data obtained through next-generation sequencing and related drug modalities such as VHH antibodies.1

The main uses of these approaches in antibody research involve2

These computational methods can provide much more cost-efficient and rapid turnaround time compared to the laborious experimental methods that are common in antibody discovery. Escalating costs are often a significant impediment to the advancement of drug discovery.


At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References:

  1. Norman, R. A., Ambrosetti, F., Bonvin, A. M., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020). Computational approaches to therapeutic antibody design: Established methods and emerging trends. Briefings in Bioinformatics, 21(5), 1549-1567. https://academic.oup.com/bib/article/21/5/1549/5581643

  2. Kim, J., McFee, M., Fang, Q., Abdin, O., & Kim, P. M. (2023). Computational and artificial intelligence-based methods for antibody development. Trends in Pharmacological Sciences, 44(3), 175–189. https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(22)00279-6


Subscribe to our Blog
Recommended Articles
BIO 2026: San Diego 2026: Highlights and Event Recap

Two popular topics discussed at the 2026 BIO International Convention were devel……

Jun 26, 2026
What Makes Antibody Characterization Data AI-Ready?

AI is changing antibody discovery, but model performance depends on the quality ……

Jun 23, 2026
Why Antibody Discovery Needs Both Faster Expression and Higher Throughput

Antibody discovery has become increasingly sequence-rich. Display technologies, ……

Jun 19, 2026
New! RushData: Biointron's Integrated Platform in the Era of AI-Driven Antibody Design

Biointron, a leading contract research organization specializing in antibody dis……

Jun 16, 2026

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.